Bixiye
QP60-21 New Form for Long-Term Acute Care, Inpatient Rehabilitation and Skilled Nursing Facility Admissions and Continued Stay Requests
Taariikhda dhaqangalka Barnaamijka: Jul 28, 2021
Natiijooyinka Raadinta
Soo bandhiga 2531 - 2540 ee natiijooyinka 4128
Bixiye
QP55-21 MHCP Pharmacy Benefit Exclusion for RybrevantTM
Taariikhda dhaqangalka Barnaamijka: Jul 14, 2021
Bixiye
QP57-21 Philips Respironics Device Recall
Taariikhda dhaqangalka Barnaamijka: Jul 14, 2021
Bixiye
QP58-21 Commercial and MHCP Pharmacy Benefit Exclusion for Vocabria
Taariikhda dhaqangalka Barnaamijka: Jul 14, 2021
Bixiye
Formulary Exception with Quantity Limit - Standard Guidelines - FlexRx and GenRx
Formulary Exception, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2025
Bixiye
Erectile Dysfunction - Phosphodiesterase Type 5 Inhibitors, Topical Prostaglandin - Commercial
Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2025
Bixiye
Enspryng (satralizumab-mwge) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025
Bixiye
Enspryng (satralizumab-mwge) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2025